DK1259250T3 - Endoparasiticide midler - Google Patents

Endoparasiticide midler

Info

Publication number
DK1259250T3
DK1259250T3 DK01911623T DK01911623T DK1259250T3 DK 1259250 T3 DK1259250 T3 DK 1259250T3 DK 01911623 T DK01911623 T DK 01911623T DK 01911623 T DK01911623 T DK 01911623T DK 1259250 T3 DK1259250 T3 DK 1259250T3
Authority
DK
Denmark
Prior art keywords
endoparasitic agents
endoparasitic
agents
Prior art date
Application number
DK01911623T
Other languages
Danish (da)
English (en)
Inventor
Jochen Kalbe
Achim Harder
Norbert Mencke
Michael Traeubel
Samson-Himmelstjerna Georg Von
Michael Stegemann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of DK1259250T3 publication Critical patent/DK1259250T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK01911623T 2000-02-22 2001-02-09 Endoparasiticide midler DK1259250T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (1)

Publication Number Publication Date
DK1259250T3 true DK1259250T3 (da) 2007-02-26

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01911623T DK1259250T3 (da) 2000-02-22 2001-02-09 Endoparasiticide midler

Country Status (25)

Country Link
US (1) US20030125244A1 (enExample)
EP (1) EP1259250B1 (enExample)
JP (2) JP5596249B2 (enExample)
KR (1) KR100755414B1 (enExample)
CN (1) CN1309415C (enExample)
AR (2) AR028218A1 (enExample)
AT (1) ATE343394T1 (enExample)
AU (2) AU4060501A (enExample)
BR (1) BR0108562B1 (enExample)
CA (1) CA2400610C (enExample)
CZ (1) CZ300242B6 (enExample)
DE (2) DE10008128A1 (enExample)
DK (1) DK1259250T3 (enExample)
ES (1) ES2274871T3 (enExample)
HK (1) HK1054326B (enExample)
HU (1) HUP0204554A3 (enExample)
IL (2) IL150988A0 (enExample)
MX (1) MXPA02008210A (enExample)
NO (1) NO328949B1 (enExample)
NZ (1) NZ520856A (enExample)
PL (1) PL203999B1 (enExample)
PT (1) PT1259250E (enExample)
RU (1) RU2292905C2 (enExample)
WO (1) WO2001062268A1 (enExample)
ZA (1) ZA200205982B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
ES2318053T3 (es) * 2002-11-12 2009-05-01 The Kitasato Institute Sustancia antihelmintica fki-1033 y procedimiento para la produccion de la misma.
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
ES2380408T3 (es) 2008-08-28 2012-05-11 Pfizer Inc. Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
MX2022001764A (es) 2019-08-14 2022-08-04 Vetoquinol Sa Composiciones que comprenden tigolaner para el control de parasitos.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
DK0634408T3 (da) * 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE295167T1 (de) * 1998-03-19 2005-05-15 Merck & Co Inc Schwefelpentafluorophenylpyrazole zur kontrolle von ektoparasitenbefall
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
PL357551A1 (en) 2004-07-26
WO2001062268A1 (de) 2001-08-30
NO20023976L (no) 2002-10-21
NZ520856A (en) 2005-04-29
ATE343394T1 (de) 2006-11-15
IL150988A0 (en) 2003-02-12
ZA200205982B (en) 2003-07-28
DE10008128A1 (de) 2001-08-23
MXPA02008210A (es) 2003-01-28
JP2003523397A (ja) 2003-08-05
CN1309415C (zh) 2007-04-11
RU2002125493A (ru) 2004-03-20
PL203999B1 (pl) 2009-11-30
HK1054326A1 (en) 2003-11-28
ES2274871T3 (es) 2007-06-01
IL150988A (en) 2011-06-30
EP1259250B1 (de) 2006-10-25
AR028218A1 (es) 2003-04-30
BR0108562B1 (pt) 2013-03-05
NO328949B1 (no) 2010-06-28
CZ20022867A3 (cs) 2003-01-15
CZ300242B6 (cs) 2009-03-25
US20030125244A1 (en) 2003-07-03
HUP0204554A3 (en) 2005-05-30
AU4060501A (en) 2001-09-03
RU2292905C2 (ru) 2007-02-10
KR20020072577A (ko) 2002-09-16
PT1259250E (pt) 2007-01-31
HK1054326B (zh) 2007-11-09
JP5596249B2 (ja) 2014-09-24
DE50111315D1 (de) 2006-12-07
NO20023976D0 (no) 2002-08-21
BR0108562A (pt) 2002-11-12
AR085989A2 (es) 2013-11-13
HUP0204554A2 (en) 2003-05-28
KR100755414B1 (ko) 2007-09-04
AU2001240605B2 (en) 2005-04-21
CA2400610A1 (en) 2001-08-30
EP1259250A1 (de) 2002-11-27
CA2400610C (en) 2013-01-22
CN1404397A (zh) 2003-03-19
JP2012107024A (ja) 2012-06-07

Similar Documents

Publication Publication Date Title
DK1309591T3 (da) Substituerede pyrazoler
CY1104912T1 (el) Υποκατεστημενα πυραζολια
DZ3409A1 (fr) Association therapeuthique
NO20030472L (no) Imidazolderivater
DE60112184D1 (de) Ejektorzyklus
DE60112185D1 (de) Signalartbestimmung
DE60133295D1 (de) Sulphoniumsalz-verbindung
NO20031869D0 (no) Antiinflammatoriske midler
DE60104308D1 (de) Rekonfigurationsverwalter
FI20002644L (fi) Liitäntäalusta
DE60107598D1 (de) Smart-skin strukturen
EE200200420A (et) Linesoliid - kristallivorm II
DE60102473D1 (de) Indolochinazolinone
EP1295028A4 (en) Shockwave injector nozzle
EP1312379A4 (en) FIBRINOGENING AGENTS
DE60121447D1 (de) Tetrazolderivate
PT1303188E (pt) Agentes herbicidas
AR028218A1 (es) Composicion endoparasiticidas
NO20024860D0 (no) Hårpleiesammensetninger
DE60129224D1 (de) Tetrazolderivate
NO20031215L (no) Difosfonatlösninger
FI20002525A7 (fi) Tulehduksenvastaisia aineita
ATE305217T1 (de) Ortho-phenylphenolat-konzentrate
AT500246B8 (de) Chokerring
FR2817889B1 (fr) Coffrage